Chemoinformaics analysis of 1-Hydroxy-2-naphthoic acid
| Molecular Weight | 188.182 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 12 |
| Exact Molecular Weight | 188.047 | nRing | 2 |
| Solubility: LogS | -3.215 | nHRing | 0 |
| Solubility: LogP | 3.381 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 26.1103 |
| nHD | 2 | BPOL | 8.89366 |
| QED | 0.721 |
| Synth | 1.627 |
| Natural Product Likeliness | 0.148 |
| NR-PPAR-gamma | 0.879 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.217 |
| CACO-2 | -5.04 |
| MDCK | 0.0000127 |
| BBB | 0.379 |
| PPB | 0.952913 |
| VDSS | 0.262 |
| FU | 0.0348302 |
| CYP1A2-inh | 0.166 |
| CYP1A2-sub | 0.106 |
| CYP2c19-inh | 0.051 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.206 |
| CYP2c9-sub | 0.097 |
| CYP2d6-inh | 0.043 |
| CYP2d6-sub | 0.103 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.063 |
| CL | 2.306 |
| T12 | 0.855 |
| hERG | 0.041 |
| Ames | 0.013 |
| ROA | 0.584 |
| SkinSen | 0.416 |
| Carcinogencity | 0.348 |
| EI | 0.903 |
| Respiratory | 0.961 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.667331 |